---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-149828"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:47:24.845030+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health regains Nasdaq equity compliance after $27M in capital events

## Summary
- Stockholders' deficit was $18.7M at Dec 31, 2025, below Nasdaq's $2.5M minimum.
- Received $16M license fee, $3M buy-back termination, $1M inventory purchase from Woodward/Future Pak.
- Also received $2M MSA condition payment, $1.2M firm order, grant revenue, and $0.2M net sales.
- Gain of $3.4M on debt extinguishment to Chicago Venture Partners helped restore equity.
- Company believes stockholders' equity exceeded $2.5M as of April 7, 2026, curing the deficiency.

## SEC filing metadata
- accession: 0001193125-26-149828
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526149828/0001193125-26-149828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526149828/d145473d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-149828
- JSON: https://secwatch.observer/filing/0001193125-26-149828.json
- Plain text: https://secwatch.observer/filing/0001193125-26-149828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.